Pfizer | PFE

Stock Price
28.10
Daily Change
0.33 1.19%
Monthly
3.12%
Yearly
-26.09%
Q2 Forecast
28.56
Peers Price Chg Day Year Date
AbbVie 156.14 1.44 0.93% 13.18% May/30
Abbott 101.74 1.01 1.00% -0.25% May/30
ALKERMES 23.35 0.06 0.26% -19.29% May/30
Amgen 300.94 4.35 1.47% 36.39% May/30
AstraZeneca 12,028.00 98.00 0.82% 3.16% May/30
Bayer 28.06 1.13 4.20% -46.19% May/30
Biogen 220.06 5.46 2.54% -25.76% May/30
Bristol-Myers Squibb 40.26 -0.04 -0.10% -37.52% May/30
Catalent 53.60 -0.02 -0.04% 43.97% May/30
Gilead Sciences 64.19 0.57 0.90% -16.57% May/30
GlaxoSmithKline 1,730.00 -16.50 -0.94% 28.49% May/30
Glaxosmithkline 44.02 -0.26 -0.59% 31.01% May/30
J&J 145.24 0.97 0.67% -6.33% May/30
Eli Lilly 816.00 2.36 0.29% 90.01% May/30
Medtronic 80.60 -1.02 -1.25% -2.61% May/30
Merck 125.58 -1.41 -1.12% 13.74% May/30
Neurocrine Biosciences 136.66 2.04 1.52% 52.64% May/30
Novartis 91.23 0.72 0.80% 4.67% May/30
Novartis 100.70 1.36 1.37% 4.62% May/30
Prestige Brands 62.80 0.18 0.29% 9.73% May/30
Pacira 30.46 1.20 4.10% -19.91% May/30
Pfizer 28.10 0.33 1.19% -26.09% May/30
Perrigo 27.55 0.42 1.55% -13.80% May/30
Drreddys Laboratories 69.86 -0.67 -0.95% 26.58% May/30
Regeneron Pharmaceuticals 972.85 3.92 0.41% 32.26% May/30
Roche Holding 228.30 -1.30 -0.57% -20.78% May/30
Sanofi 88.57 0.86 0.98% -6.65% May/30
Sanofi 47.84 0.31 0.65% -6.23% May/30
Vertex Pharmaceuticals 443.05 1.79 0.41% 36.93% May/30
Zoetis 169.18 -1.62 -0.95% 3.79% May/30

Indexes Price Day Year Date
US500 5232 -31.47 -0.60% 23.95% May/31

Pfizer traded at $28.10 this Thursday May 30th, increasing $0.33 or 1.19 percent since the previous trading session. Looking back, over the last four weeks, Pfizer gained 3.12 percent. Over the last 12 months, its price fell by 26.09 percent. Looking ahead, we forecast Pfizer to be priced at 28.56 by the end of this quarter and at 27.74 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.